What is the potential impact of US marijuana reclassification on Tilray?

A potential reclassification to Schedule III could allow Tilray to deduct business expenses and improve banking access, likely boosting its stock performance.

Did Tilray's stock increase recently?

Yes, Tilray's stock surged 44% on Friday following reports of a possible US marijuana reclassification.

What were Tilray's recent financial results?

In fiscal Q1 2026, Tilray reported record revenue of $210 million and a net income of $1.5 million.

Home / Business and Economy / Trump Order Could Spark Cannabis Stock Boom

Trump Order Could Spark Cannabis Stock Boom

17 Dec

•

Summary

US may reclassify marijuana to Schedule III, impacting cannabis stocks.
Tilray's stock surged 44% on Friday due to potential reclassification.
Tilray reported record revenue of $210 million in fiscal Q1 2026.

Trump Order Could Spark Cannabis Stock Boom

Reports indicate a potential executive order from President Trump that could reclassify marijuana from a Schedule I drug to the less restrictive Schedule III category. This change would significantly benefit cannabis companies by allowing business expense deductions under IRS rules and improving access to banking services. Such a development has already spurred a surge in Canadian cannabis stocks, with Tilray (TLRY) experiencing a notable 44% increase on Friday alone.

Tilray, a major player in the global cannabis market with a $1.4 billion valuation, reported strong financial performance in its fiscal first quarter of 2026, ending in August. The company achieved record revenue of $210 million, marking a 5% year-over-year increase. This growth was fueled by double-digit gains in both domestic and international cannabis markets, with adult-use sales in Canada rising 12% and international revenue climbing 10% year-over-year, despite facing some headwinds.